Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
Cinda: Global liquidity has tightened and the US dollar index may enter a period of wide fluctuations in the second half of the year.
New stock news | Yongkang Holdings passed the hearing of the Hong Kong Stock Exchange and operates 18 container yards at 10 locations.
CMSC: Short-term focus on copper prices tightening liquidity and changes in geopolitical risks. In the medium to long term, we still see the evolution of supply and demand patterns.
Cinda: Global liquidity has tightened and the US dollar index may enter a period of wide fluctuations in the second half of the year.
New stock news | Yongkang Holdings passed the hearing of the Hong Kong Stock Exchange and operates 18 container yards at 10 locations.
CMSC: Short-term focus on copper prices tightening liquidity and changes in geopolitical risks. In the medium to long term, we still see the evolution of supply and demand patterns.
RECOMMEND
